兰州大学学报(医学版)
蘭州大學學報(醫學版)
란주대학학보(의학판)
JOURNAL OF LANZHOU UNIVERSITY(MEDICAL SCIENCES)
2015年
3期
38-45
,共8页
亢婷%王刚%刘毅%刘刚强
亢婷%王剛%劉毅%劉剛彊
항정%왕강%류의%류강강
组织工程脂肪%血管内皮生长因子165%人脂肪间充质干细胞%壳聚糖%丝素蛋白%支架
組織工程脂肪%血管內皮生長因子165%人脂肪間充質榦細胞%殼聚糖%絲素蛋白%支架
조직공정지방%혈관내피생장인자165%인지방간충질간세포%각취당%사소단백%지가
tissue engineered adipose%vascular endothelial growth factor 165%human adipose derived mesen-chymal stem cell%chitosan%silk fibroin%scaffold
目的:探讨血管内皮生长因子165(VEGF165)基因修饰的人脂肪间充质干细胞(hADSCs)与壳聚糖修饰的丝素蛋白支架材料体内构建血管化组织工程脂肪的可行性。方法分离提取hADSCs,选取生长状态良好的第3代hADSCs,用携带重组人VEGF165基因的慢病毒进行感染(感染复数=50)。选用慢病毒感染和未感染的第3代hADSCs分别接种于支架材料上,记为实验组与对照组,同时成脂诱导5 d后,使用氯甲基苯甲酰胺标记细胞。取24只雌性Wistar大鼠,将上述实验组与对照组细胞—支架复合物移植于背部皮下,每组12只。移植后8,12周分别取材并行冰冻切片、HE染色、油红O染色及扫描电镜,同时观察支架材料的降解情况,观察移植物。免疫印迹法检测VEGF165及过氧化物酶体增殖体激活受体-γ2(PPARγ-2)蛋白的表达。结果移植后8,12周,免疫印迹法结果显示实验组移植物均表达VEGF165,对照组未见表达;实验组与对照组均表达PPARγ-2,实验组中的表达量明显多于对照组(P<0.05)。扫描电镜、油红O染色及HE染色均表明实验组与对照组生成大量脂肪样细胞,且实验组明显多于对照组(P<0.05)。结论携带重组人VEGF165基因的慢病毒感染的hADSCs与壳聚糖/丝素蛋白支架材料复合物在大鼠体内可持续表达VEGF165及PPARγ-2蛋白,能显著促进工程化脂肪组织的构建,为血管化组织工程脂肪的构建奠定了基础。
目的:探討血管內皮生長因子165(VEGF165)基因脩飾的人脂肪間充質榦細胞(hADSCs)與殼聚糖脩飾的絲素蛋白支架材料體內構建血管化組織工程脂肪的可行性。方法分離提取hADSCs,選取生長狀態良好的第3代hADSCs,用攜帶重組人VEGF165基因的慢病毒進行感染(感染複數=50)。選用慢病毒感染和未感染的第3代hADSCs分彆接種于支架材料上,記為實驗組與對照組,同時成脂誘導5 d後,使用氯甲基苯甲酰胺標記細胞。取24隻雌性Wistar大鼠,將上述實驗組與對照組細胞—支架複閤物移植于揹部皮下,每組12隻。移植後8,12週分彆取材併行冰凍切片、HE染色、油紅O染色及掃描電鏡,同時觀察支架材料的降解情況,觀察移植物。免疫印跡法檢測VEGF165及過氧化物酶體增殖體激活受體-γ2(PPARγ-2)蛋白的錶達。結果移植後8,12週,免疫印跡法結果顯示實驗組移植物均錶達VEGF165,對照組未見錶達;實驗組與對照組均錶達PPARγ-2,實驗組中的錶達量明顯多于對照組(P<0.05)。掃描電鏡、油紅O染色及HE染色均錶明實驗組與對照組生成大量脂肪樣細胞,且實驗組明顯多于對照組(P<0.05)。結論攜帶重組人VEGF165基因的慢病毒感染的hADSCs與殼聚糖/絲素蛋白支架材料複閤物在大鼠體內可持續錶達VEGF165及PPARγ-2蛋白,能顯著促進工程化脂肪組織的構建,為血管化組織工程脂肪的構建奠定瞭基礎。
목적:탐토혈관내피생장인자165(VEGF165)기인수식적인지방간충질간세포(hADSCs)여각취당수식적사소단백지가재료체내구건혈관화조직공정지방적가행성。방법분리제취hADSCs,선취생장상태량호적제3대hADSCs,용휴대중조인VEGF165기인적만병독진행감염(감염복수=50)。선용만병독감염화미감염적제3대hADSCs분별접충우지가재료상,기위실험조여대조조,동시성지유도5 d후,사용록갑기분갑선알표기세포。취24지자성Wistar대서,장상술실험조여대조조세포—지가복합물이식우배부피하,매조12지。이식후8,12주분별취재병행빙동절편、HE염색、유홍O염색급소묘전경,동시관찰지가재료적강해정황,관찰이식물。면역인적법검측VEGF165급과양화물매체증식체격활수체-γ2(PPARγ-2)단백적표체。결과이식후8,12주,면역인적법결과현시실험조이식물균표체VEGF165,대조조미견표체;실험조여대조조균표체PPARγ-2,실험조중적표체량명현다우대조조(P<0.05)。소묘전경、유홍O염색급HE염색균표명실험조여대조조생성대량지방양세포,차실험조명현다우대조조(P<0.05)。결론휴대중조인VEGF165기인적만병독감염적hADSCs여각취당/사소단백지가재료복합물재대서체내가지속표체VEGF165급PPARγ-2단백,능현저촉진공정화지방조직적구건,위혈관화조직공정지방적구건전정료기출。
Objective To explore the feasibility to construct vascularized tissue engineered adipose with human adipose-derived mesenehymal stem cells (hADSCs) modified by human vascular endothelial growth factors 165(VEGF165) gene and a novel 3-D silk fibroin scaffold modified by chitosan (CS/SF) in vivo. Methods Isolated, cultured human adipose derived stem cells to the third generation(P3 hADSCs), then infected the cells with lentivirus vector carrying human recombinant VEGF165 gene(MOI=50). Infected and uninfected P3 hADSCs seeded on CS/SF were set as experimental group (E) and control group (C) respectively, both <br> groups were induced by adipogenic differentiation medium for 5 days and labelled by CM-DIL. 24 female Wistar rats were divided into two groups, 12 in each one. Cell-scaffold complexs were transplanted under subcutaneous layer in the rats. 8 weeks and 12 weeks later, complexes in each group were taken out and ex-amined for frozen section, HE staining, oil red O staining and scanning electron microscopy, scaffold degra-dation was also observed at the same time. The expression of VEGF165 and PPARγ-2 were detected by Western bolt. Results 8 weeks and 12 weeks after implanted, Western blot results showed that the grafts in E group expressed VEGF165, while no expression were found in C group. Both E and C group expressed PPARγ-2, the expression levels of PPARγ-2 in E group was higher than those in C group (P<0.05). Scan-ning electron microscopy, oil red O staining and HE staining all showed that E and C groups both generated a lot of fat cells, furthermore the numbers of fat cells in E group was higher than that in C group (P<0.05). Conclusion Complexes of hADSCs infected by lentivirus vector carrying human recombinant VEGF165 gene and CS/SF could not only continuously express VEGF165 and PPARγ-2 in rats, but also promote to reconstruct tissue engineered adipose, this result might lay a solid foundation to reconstruct vascularized tissue engineered fat in vivo.